This study aimed to assess the impact iso-BCFA supplementation on hyperlipidaemia and inflammation in atherosclerotic apolipoprotein E and low-density lipoprotein receptor double knockout (ApoE−/−/Ldlr−/−) mice. This evidence concerns the gene VLDLR and hyperlipidemia.